サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1458770

酵母感染症治療の世界市場レポート 2024年

Yeast Infection Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
酵母感染症治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

酵母感染症治療市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.3％で55億3,000万米ドルに成長します。過去の期間に見られた成長は、イースト菌感染症の有病率の高まり、真菌感染症に関する意識の高まり、人口の高齢化、世界のヘルスケア支出の増加、新しい抗真菌薬の開発と承認など、いくつかの要因によるものです。

予測される自己免疫疾患の増加は、当面の酵母感染症治療市場の拡大を牽引すると予測されます。自己免疫疾患は、免疫系が誤って健康な細胞や組織、臓器を攻撃し、身体機能の低下や生命を脅かす合併症を引き起こす可能性があります。酵母感染症治療は、特定の自己免疫症候群に関連する再発性イースト菌感染症に対処することにより、自己免疫疾患の合併症を管理・予防する上で重要な役割を果たしています。さらに、自己免疫疾患患者の真菌感染症を管理することにより、免疫反応を調節する可能性もあります。例えば、2023年3月現在、米国国立衛生研究所（National Institutes of Health）は、2021年の1型糖尿病（T1DM）の世界患者数は840万人と推定され、その年に50万人の新規患者が報告されたと報告しています。予測では、T1DM人口は2040年までに1,350万人から1,740万人に達するとされています。したがって、自己免疫疾患の有病率の増加が酵母感染症治療市場の成長を促進しています。

酵母感染症治療市場の主要企業は、競争力を高めるために非アゾール系経口抗真菌薬などの革新的なソリューションの導入に注力しています。非アゾール系経口抗真菌薬とは、アゾール系に属することなく真菌感染症に対処するように設計された薬剤です。例えば、米国のバイオテクノロジー企業であるSCYNEXIS社は、2022年12月、米国食品医薬品局（FDA）から2つ目の適応となるBREXAFEMME（イブレキサファンガープ錠）の承認を取得しました。BREXAFEMMEは先駆的な非アゾール系経口抗真菌薬であり、膣イースト菌感染症（外陰カンジダ症、VVC）の治療およびVVCの再発抑制を適応とする初めてのFDA承認の治療薬です。BREXAFEMMEは広範囲に作用するため、新しい選択肢を提供し、再発性外陰カンジダ症患者の限られた治療選択肢に対応し、市場情勢を再構築します。BREXAFEMMEのVVC治療における推奨用量は、300mg（150mg×2錠）を1日1回、合計600mg（150mg×4錠）を1日1回です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の酵母感染症治療市場、タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 粉末
  • クリームまたは軟膏
  • 錠剤またはカプセル
  • その他のタイプ
  • 世界の酵母感染症治療市場、治療別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 医療
  • 手術
  • 世界の酵母感染症治療市場、適応症別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 性器カンジダ症
  • 侵襲性カンジダ症
  • 口腔咽頭または食道カンジダ症（カンジダ症）
  • その他の適応症
  • 世界の酵母感染症治療市場、投与経路別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 経口
  • 外用
  • IV（静脈内）またはIM（筋肉内）
  • その他の投与経路
  • 世界の酵母感染症治療市場、用途別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 小売薬局またはドラッグストア
  • 病院薬局
  • 専門店
  • オンライン販売
  • その他の用途

第7章 地域別・国別分析

  • 世界の酵母感染症治療市場、地域別、実績および予測、2018～2023年、2023～2028年、2033年
  • 世界の酵母感染症治療市場、国別、実績および予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 酵母感染症治療市場の競合情勢
  • 酵母感染症治療市場企業プロファイル
    • Pfizer Inc.
    • Merck &Co. Inc.
    • AbbVie Inc.
    • Novartis International AG
    • Sanofi SA

第31章 その他の大手企業と革新的企業

  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • Astellas Pharma Inc.
  • Torrent Pharmaceuticals
  • Catalent Inc.
  • bioMerieux SA
  • Cipla
  • Bruker Corporation
  • Brundavan Laboratories Private Limited
  • Glenmark Pharmaceuticals Ltd
  • Zydus Lifesciences
  • Prestige Consumer Healthcare Inc.
  • CordenPharma International

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的分析

第36章 付録

目次
Product Code: r16752

Yeast infection treatment refers to medications utilized to address infections resulting from Candida fungus overgrowth, commonly known as yeast infections or candidiasis. These infections can manifest in various body parts such as the mouth (oral thrush), genitals (vaginal yeast infection), skin, and mucous membranes. The treatments aim to alleviate yeast infection symptoms.

Yeast infection treatment come in different forms such as powders, creams, ointments, tablets, or capsules, and can involve medical treatment or surgery. Indications for these treatments include genital candidiasis, invasive candidiasis, oropharyngeal or esophageal candidiasis (thrush), among others. Administration routes include oral, topical, IV (intravenous), or IM (intramuscular), and the treatments are utilized across various applications such as retail pharmacies, hospital pharmacies, specialty stores, online sales, and more.

The yeast infection treatment market research report is one of a series of new reports from The Business Research Company that provides yeast infection treatment market statistics, including yeast infection treatment industry global market size, regional shares, competitors with a yeast infection treatment market share, detailed yeast infection treatment market segments, market trends and opportunities, and any further data you may need to thrive in the yeast infection treatment industry. This yeast infection treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The yeast infection treatment market size has grown strongly in recent years. It will grow from $4.02 billion in 2023 to $4.33 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed during the historical period can be attributed to several factors, including the increased prevalence of yeast infections, rising awareness about fungal infections, the aging population, the global increase in healthcare expenditure, and the development and approval of new antifungal medications.

The yeast infection treatment market size is expected to see strong growth in the next few years. It will grow to $5.53 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period can be attributed to several factors, including the heightened prevalence of yeast infections, increased awareness regarding fungal infections, an aging population, the global escalation of healthcare expenditure, and the development and approval of new antifungal medications.

The anticipated increase in autoimmune disease prevalence is forecasted to drive the expansion of the yeast infection treatment market in the foreseeable future. Autoimmune diseases involve the immune system mistakenly attacking healthy cells, tissues, and organs, leading to weakened bodily functions and potentially life-threatening complications. Yeast infection treatments play a crucial role in managing and preventing autoimmune disease complications by addressing recurrent yeast infections associated with certain autoimmune syndromes. Additionally, they may modulate the immune response by managing fungal infections in patients with autoimmune conditions. For instance, as of March 2023, the National Institutes of Health reported an estimated 8.4 million global cases of type 1 diabetes (T1DM) in 2021, with 500,000 new cases reported that year. Projections indicate the T1DM population to reach between 13.5 and 17.4 million by 2040. Hence, the increasing prevalence of autoimmune diseases is fostering the growth of the yeast infection treatment market.

Key players in the yeast infection treatment market are concentrating on introducing innovative solutions, such as non-azole oral antifungals, to enhance their competitive position. A non-azole oral antifungal is a medication designed to combat fungal infections without belonging to the azole class. For instance, in December 2022, SCYNEXIS, a US-based biotechnology company, received approval from the United States Food and Drug Administration (FDA) for BREXAFEMME (ibrexafungerp tablets), marking its second indication. BREXAFEMME is a pioneering non-azole oral antifungal, the first FDA-endorsed therapy for treating vaginal yeast infections (vulvovaginal candidiasis, VVC) and reducing the recurrence of VVC. With its broad-spectrum activity, BREXAFEMME provides a novel alternative, addressing the limited treatment options for patients with recurrent VVC and reshaping the yeast infection treatment market landscape. The recommended dosage of BREXAFEMME for VVC treatment is 300 mg (two 150 mg tablets) administered one day apart, totaling 600 mg (four 150 mg tablets) daily.

In February 2021, SCYNEXIS, a biotechnology company based in the United States known for developing medicines to treat vaginal yeast infections, entered into a partnership with Amplity Health for an undisclosed sum. This collaboration aims to support the anticipated commercialization of Brexafemme (Ibrexafungerp) for vaginal yeast infections in the United States. Additionally, the partnership leverages Amplity Health's commercial sales capabilities alongside SCYNEXIS' internal marketing expertise to facilitate the U.S. commercialization of Brexafemme. Brexafemme stands as the first and only oral non-azole treatment for vaginal yeast infections, with the goal of reducing the occurrence of recurrent vaginal yeast infections. Amplity Health operates as a contract medical and commercial organization based in the United States.

Major companies operating in the yeast infection treatment market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi SA, Thermo Fisher Scientific Inc., Abbott Laboratories, AstraZeneca PLC, Bayer AG, Astellas Pharma Inc., Torrent Pharmaceuticals, Catalent Inc., bioMerieux SA, Cipla, Bruker Corporation, Brundavan Laboratories Private Limited, Glenmark Pharmaceuticals Ltd, Zydus Lifesciences, Prestige Consumer Healthcare Inc., CordenPharma International, Synmedic Laboratories, Basilea Pharmaceutica AG, Jubilant Pharmova Limited, Curia Global Inc., Synexis LLC, Manus Aktteva Biopharma LLP

North America was the largest region in the yeast infection treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yeast infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yeast infection treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The yeast infection treatment market consists of revenues earned by entities by providing diagnostic testing, personalized treatment plans, telemedicine consultations, educational programs and more. The market value includes the value of related goods sold by the service provider or included within the service offering. The yeast infection treatment market also includes sales of miconazole, terconazole, fluconazole, amphotericin B, itraconazole, and caspofungin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Yeast Infection Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on yeast infection treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for yeast infection treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The yeast infection treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Powders; Creams Or Ointments; Tablets Or Capsules; Other Types
  • 2) By Treatment: Medical Treatment; Surgery
  • 3) By Indication: Genital Candidiasis; Invasive Candidiasis; Oropharyngeal Or Esophageal Candidiasis (Thrush); Other Indications
  • 4) By Route Of Administration: Oral; Topical; IV (Intravenous) Or IM (Intramuscular); Other Routes Of Administration
  • 5) By Application: Retail Pharmacies Or Drug Stores; Hospital Pharmacies; Specialty Stores; Online Sales; Other Applications
  • Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis International AG; Sanofi SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Yeast Infection Treatment Market Characteristics

3. Yeast Infection Treatment Market Trends And Strategies

4. Yeast Infection Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Yeast Infection Treatment Market Size and Growth

  • 5.1. Global Yeast Infection Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Yeast Infection Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Yeast Infection Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Yeast Infection Treatment Market Segmentation

  • 6.1. Global Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Powders
  • Creams Or Ointments
  • Tablets Or Capsules
  • Other Types
  • 6.2. Global Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medical Treatment
  • Surgery
  • 6.3. Global Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genital Candidiasis
  • Invasive Candidiasis
  • Oropharyngeal Or Esophageal Candidiasis (Thrush)
  • Other Indications
  • 6.4. Global Yeast Infection Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Topical
  • IV (Intravenous) Or IM (Intramuscular)
  • Other Routes Of Administration
  • 6.5. Global Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Retail Pharmacies Or Drug Stores
  • Hospital Pharmacies
  • Specialty Stores
  • Online Sales
  • Other Applications

7. Yeast Infection Treatment Market Regional And Country Analysis

  • 7.1. Global Yeast Infection Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Yeast Infection Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Yeast Infection Treatment Market

  • 8.1. Asia-Pacific Yeast Infection Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Yeast Infection Treatment Market

  • 9.1. China Yeast Infection Treatment Market Overview
  • 9.2. China Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Yeast Infection Treatment Market

  • 10.1. India Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Yeast Infection Treatment Market

  • 11.1. Japan Yeast Infection Treatment Market Overview
  • 11.2. Japan Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Yeast Infection Treatment Market

  • 12.1. Australia Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Yeast Infection Treatment Market

  • 13.1. Indonesia Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Yeast Infection Treatment Market

  • 14.1. South Korea Yeast Infection Treatment Market Overview
  • 14.2. South Korea Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Yeast Infection Treatment Market

  • 15.1. Western Europe Yeast Infection Treatment Market Overview
  • 15.2. Western Europe Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Yeast Infection Treatment Market

  • 16.1. UK Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Yeast Infection Treatment Market

  • 17.1. Germany Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Yeast Infection Treatment Market

  • 18.1. France Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Yeast Infection Treatment Market

  • 19.1. Italy Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Yeast Infection Treatment Market

  • 20.1. Spain Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Yeast Infection Treatment Market

  • 21.1. Eastern Europe Yeast Infection Treatment Market Overview
  • 21.2. Eastern Europe Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Yeast Infection Treatment Market

  • 22.1. Russia Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Yeast Infection Treatment Market

  • 23.1. North America Yeast Infection Treatment Market Overview
  • 23.2. North America Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Yeast Infection Treatment Market

  • 24.1. USA Yeast Infection Treatment Market Overview
  • 24.2. USA Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Yeast Infection Treatment Market

  • 25.1. Canada Yeast Infection Treatment Market Overview
  • 25.2. Canada Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Yeast Infection Treatment Market

  • 26.1. South America Yeast Infection Treatment Market Overview
  • 26.2. South America Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Yeast Infection Treatment Market

  • 27.1. Brazil Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Yeast Infection Treatment Market

  • 28.1. Middle East Yeast Infection Treatment Market Overview
  • 28.2. Middle East Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Yeast Infection Treatment Market

  • 29.1. Africa Yeast Infection Treatment Market Overview
  • 29.2. Africa Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Yeast Infection Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Yeast Infection Treatment Market Competitive Landscape
  • 30.2. Yeast Infection Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis International AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sanofi SA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Yeast Infection Treatment Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific Inc.
  • 31.2. Abbott Laboratories
  • 31.3. AstraZeneca PLC
  • 31.4. Bayer AG
  • 31.5. Astellas Pharma Inc.
  • 31.6. Torrent Pharmaceuticals
  • 31.7. Catalent Inc.
  • 31.8. bioMerieux SA
  • 31.9. Cipla
  • 31.10. Bruker Corporation
  • 31.11. Brundavan Laboratories Private Limited
  • 31.12. Glenmark Pharmaceuticals Ltd
  • 31.13. Zydus Lifesciences
  • 31.14. Prestige Consumer Healthcare Inc.
  • 31.15. CordenPharma International

32. Global Yeast Infection Treatment Market Competitive Benchmarking

33. Global Yeast Infection Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Yeast Infection Treatment Market

35. Yeast Infection Treatment Market Future Outlook and Potential Analysis

  • 35.1 Yeast Infection Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Yeast Infection Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Yeast Infection Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer